Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathologic Changes of IgA Nephropathy in Children During Long-term (average 10.8 yrs) Follow-up

소아 IgA 신병증의 장기 추적(평균 10.8년)에 따른 임상 경과 및 병리학적 변화

  • Moon, Chang-Min (Department of Pediatrics, Kwandong University, College of Medicine) ;
  • Kim, Pyung-Kil (Department of Pediatrics, Kwandong University, College of Medicine) ;
  • Lim, Beom-Jin (Department of Pathology, Yonsei University, College of Medicine) ;
  • Song, Ji-Sun (Department of Pathology, Kwandong University, College of Medicine) ;
  • Jeong, Hyeon-Joo (Department of Pathology, Yonsei University, College of Medicine)
  • 문창민 (관동대학교 의과대학 소아과학교실) ;
  • 김병길 (관동대학교 의과대학 소아과학교실) ;
  • 임범진 (연세대학교 의과대학 병리학교실) ;
  • 송지선 (관동대학교 의과대학 병리학교실) ;
  • 정현주 (연세대학교 의과대학 병리학교실)
  • Received : 2010.09.20
  • Accepted : 2010.10.08
  • Published : 2010.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : We know little about the natural course of IgA nephropathy (IgAN) in association with histologic changes especially in children. We investigated clinicopathologic features with long-term follow-up biopsy to clarify the outcomes and prognostic indicators for childhood IgAN. Methods : From our patients' medical records, we retrieved 20 patients with IgAN, to whom renal biopsies had been performed for the initial diagnosis and follow-up to find out any histologic changes. Initial and follow-up biopsies were classified by Haas classification. The changes of these parameters were compared with the evolution of clinical features. Results : Patients were treated with angiotensin-converting enzyme inhibitors in combination with angiotensin receptor blockers (in subclass II or above) and short-term cyclosporine A(in patients showing nephrotic syndrome). Histologic improvement in 7 cases and deterioration in 3 cases were observed. At the time of last biopsy, 10 cases (50%) showed clinical remission and the others showed improved clinical features. These clinical outcomes did not correlate with initial Haas classifications. Hypertension at onset observed in 5 cases (25%) revealed significant correlation with clinical outcome (P =0.01) and last Haas classification (P =0.007). None of the cases showed progression to CRF or ESRD. Conclusion : During a mean follow-up of $10.8{\pm}3.4$ years, childhood IgAN showed good clinicopathologic outcome. Hypertension at onset was only a strong predictor of clinicopathologic outcomes, but initial Haas classification cannot predict outcomes in children. Histologic change of IgAN in long term follow-up period cannot be completely predicted by clinical data and vice versa. Therefore, a renal biopsy should be considered as a part of follow-up plan.

목 적 : 소아 IgA 신병증의 임상 양상 및 병리학적 분류(Haas 분류)와 임상 경과와의 상관 관계를 조사하여 이들이 예후를 반영할 수 있는지 알아보고자 하였다. 방 법 : 병리학적으로 IgA 신병증으로 진단받고 추적 중이던 환자들 중 추적 신생검을 시행한 20명의 환자를 대상으로 후향적으로 자료를 분석하였다. 결 과 : 최초 신생검시 평균 9.5세였고 남자 16명, 여자 4명이었으며, 최종 조직 검사까지 평균 10.8년이 경과하였다. 안지오텐신 전환효소 억제제 등으로 치료를 지속한 후 정상뇨 소견, 정상 혈압, 정상 크레아티닌 청소율(CCr)을 보이는 임상적 관해 상태의 환자는 10명(50%)이었으며, 비관해 상태의 환자 10명(50%)도 초기와 비교하여 호전된 경과를 보였고, CCr이 중등도 이상 저하되거나 말기 신질환 양상을 보이는 환자는 없었다. 최초 Haas 분류는 임상경과와 상관 관계가 없었다. 초기 고혈압은 5명(25%)에서 보였고 이는 임상 경과(P =0.010) 및 최종 Haas 분류(P =0.007)와 유의성이 있었다. 초기 CCr의 중등도 저하는 Haas 분류와 유의성이 있었으나(P =0.048), 임상 경과와는 상관관계가 없었다. 결 론 : 소아 IgA 신병증의 추적 기간 중 임상 경과는 양호하나 최초 Haas 분류로 임상 경과를 예측할 수는 없었으나 적극적인 조기 진단 및 치료로 말기 신질환으로의 진행을 지연시킬 수 있을 것으로 보인다. 초기 고혈압은 임상 경과 및 최종 Haas 분류와 유의한 상관관계를 보여 적합한 예후인자로 보인다. 최초 병리학적 소견은 임상 경과를 반영하지 못하나, 추적 Haas 분류가 예후를 반영할 수 있을지에 대해서는 보다 많은 추적 관찰 및 추적 신생검을 통한 연구가 있어야 할 것으로 보인다.

Keywords

References

  1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;64:709-27.
  2. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12:340-7. https://doi.org/10.1016/S0272-6386(88)80021-0
  3. Berger J, Hinglais N. [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris) 1968; 74:694-5.
  4. Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int 2002;61:1079-85. https://doi.org/10.1046/j.1523-1755.2002.00193.x
  5. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000;57:1818-35. https://doi.org/10.1046/j.1523-1755.2000.00032.x
  6. Galla JH. Molecular genetics in IgA nephropathy. Nephron 2001;88:107-12. https://doi.org/10.1159/000045969
  7. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004;24:179-96. https://doi.org/10.1016/j.semnephrol.2004.01.001
  8. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005;18:503-12.
  9. Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007;49:763-75. https://doi.org/10.1053/j.ajkd.2007.03.013
  10. Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, Tamakoshi A, et al. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 2006;21: 2800-8.
  11. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology (Carlton) 2008;13:242- 6. https://doi.org/10.1111/j.1440-1797.2007.00898.x
  12. Lee JK, Moon JS, Choi JM, Nam CM, Lee SY, Oh K, et al. Normative blood pressure references for Korean children and adolescents. Korean J Pediatr 2008;51:33-41. https://doi.org/10.3345/kjp.2008.51.1.33
  13. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997;29:829-42. https://doi.org/10.1016/S0272-6386(97)90456-X
  14. Kim PK. Renal transplantation in Korean children: cooperative study. J Korean Soc Transplant 1997;11:217-24.
  15. Kim KH, Yae SJ, Kim JS, Kwon TG, Chung SK. Clinical Experience of 27 Pediatric Renal Transplantation at a Single Center. Korean J Urol 2007;48:72-6. https://doi.org/10.4111/kju.2007.48.1.72
  16. Kim SJ, Jung IM, Jung SE, Kim MY, Lee TS, Ha JW, et al. Experience with 129 Pediatric (<21yr) Kidney Transplantations. J Lorean Surg Soc 1999;56:886-97.
  17. Lee SY, Han H, Park YS, Han DJ. Clinical Experience of 60 Pediatric Renal Transplantations at a Single Center. Korean J Pediatr 2004;47:55-65.
  18. Kwon JH, Choi EN, Park JM, Lee JS, Jeung HJ. A Clinicopathological Study on the Prognosis of IgA Nephropathy in Children. J Korean Soc Pediatr Nephrol 2003;7:23-9.
  19. Han BM, Cho JY, Chuon KW, Namgoong MK. Study for Clinical Indicators of Prediction for Histological Finding of IgA Nephropathy. J Korean Soc Pediatr Nephrol 2003;7:150-6.
  20. Yoshikawa N, Ito H, Nakamura H. Prognostic indicators in childhood IgA nephropathy. Nephron 1992;60:60-7. https://doi.org/10.1159/000186706
  21. Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JC, Savino DA. Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994;8:15-20. https://doi.org/10.1007/BF00868251
  22. Santos NM, Ault BH, Gharavi AG, Kritchevsky SB, Quasney MW, Jackson EC, et al. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 2002;17:496-502. https://doi.org/10.1007/s00467-002-0916-0
  23. Woo SI, Bae KW, Lee JH, Park YS, Cho YM. Clinicopathologic features and prognosis of childhood IgA nephropathy. Korean J Pediatr 2007;50:170-7. https://doi.org/10.3345/kjp.2007.50.2.170
  24. Lee JK. Standard blood pressure of child and adolescent in 2005. Program and Abstract, 56th Annual Spring Meeting of The Korean Pediatric Society; 2006 Apr 28-29; Yong-Pyung, Seoul : The Korean Pediatric Society 2006:63-90.
  25. Andreoli SP, Yum MN, Bergstein JM. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA. Am J Nephrol 1986;6:28-33. https://doi.org/10.1159/000167049
  26. Delos Santos NM, Wyatt RJ. Pediatric IgA nephropathies: clinical aspects and therapeutic approaches. Semin Nephrol 2004;24: 269-86. https://doi.org/10.1016/j.semnephrol.2004.01.007
  27. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 2003;14: 1578-83. https://doi.org/10.1097/01.ASN.0000068460.37369.DC
  28. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43(5 Suppl 1):S1-290.
  29. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349:1857-63. https://doi.org/10.1016/S0140-6736(96)11445-8
  30. Kanno Y, Okada H, Saruta T, Suzuki H. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up. Clin Nephrol 2000;54:360-5.
  31. Ballardie FW. IgA nephropathy treatment 25 years on: can we halt progression? The evidence base. Nephrol Dial Transplant 2004;19:1041-6. https://doi.org/10.1093/ndt/gfh208
  32. Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, et al. Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant 2006;21:3466-74. https://doi.org/10.1093/ndt/gfl455
  33. Park YH, Choi JY, Chung HS, Koo JW, Kim SY, Namgoong MK, et al. Hematuria and proteinuria in a mass school urine screening test. Pediatr Nephrol 2005;20:1126-30. https://doi.org/10.1007/s00467-005-1915-8

Cited by

  1. 학교 집단 요검사로 조기 진단된 IgA 신증 환아의 임상적 특징 vol.17, pp.2, 2010, https://doi.org/10.3339/jkspn.2013.17.2.49
  2. Clinical Manifestations and Prognostic Factors of IgA Nephropathy with Long-Term Follow-Up vol.88, pp.1, 2010, https://doi.org/10.3904/kjm.2015.88.1.46